National Park Service (NPS) fire managers anticipate initiating prescribed fire treatment for the Shoshone Rx during the week of April 27 as weather and fuel moisture conditions allow. https://www.nps.gov/grca/learn/news/shoshone-rx.htm

Grand Canyon National Park, the National Park Service Office of Public Health, Coconino County Public Health Services District, and other park partners are investigating a positive case of tick-borne relapsing fever (TBRF) contracted by a recent visitor to the North Rim. https://www.nps.gov/grca/learn/news/tick-borne-relapsing-fever.htm

National Park Service fire managers anticipate initiating a prescribed fire near Shoshone Point Monday, December 7 as weather and fuel moisture conditions allow. https://www.nps.gov/grca/learn/news/shoshone-point-prescribed-fire.htm

National Park Service fire managers anticipate initiating a prescribed fire near Shoshone Point Thursday, June 9 as weather and fuel moisture conditions allow. https://www.nps.gov/grca/learn/news/shoshone-prescribed-fire-june-9.htm

Yesterday, National Park Service (NPS) fire managers successfully treated 994 acres with prescribed (Rx) fire on the South Rim of Grand Canyon. https://www.nps.gov/grca/learn/news/shoshone-rx-success.htm

Grand Canyon National Park is advising hikers that they need to treat their drinking water at the following locations: Indian Garden **NEW LOCATION** Cottonwood Campground Manzinita Resthouse https://www.nps.gov/grca/learn/news/water-treatment-advisory.htm

Hydration while hiking is critical to human health-- ensure that you are drinking enough water for physical activity. Grand Canyon National Park is advising hikers that they need to treat their drinking water at the following locations: Cottonwood Campground Manzinita Resthouse https://www.nps.gov/grca/learn/news/update-water-treatment-advisory.htm

Hydration while hiking is critical to human health- ensure that you are drinking enough water for physical activity. https://www.nps.gov/grca/learn/news/updated-water-treatment-advisory-lifted.htm

The procedure, which has only been conducted a few times in history, could be a groundbreaking new treatment for patients suffering from lung cancer.

The post In a Revolutionary Medical Treatment, Man’s Lung Was Removed, Cleaned, and Replaced—No Transplant Necessary appeared first on Good News Network.

New York's Gov. Andrew Cuomo plans to pursue the treatment following its relative success in treating influenza and Ebola.

The post FDA Okays Historic Blood Treatment for COVID; Clinical Trials to Use Antibodies From Recovered Patients appeared first on Good News Network.

Not only did the patients experience high rates of remission, their cognitive function also showed marked improvement as well.

The post Magnetic Brain Treatment Found to Relieve Depression in 90% of Participants With No Negative Side Effects appeared first on Good News Network.

The researchers from Queen Mary University of London say the discovery could lead to ground-breaking treatments with “a reduced chance of side effects.”

The post Antibodies Could Be ‘Radically Life-Changing’ New Treatment for OCD and Other Mental Disorders appeared first on Good News Network.

Cofiring wood and coal at Fairbanks, Alaska, area electrical generation facilities represents an opportunity to use woody biomass from clearings within the borough's wildland-urban interface and from other sources, such as sawmill residues and woody material intended for landfills. Potential benefits of cofiring include air quality improvements, reduced greenhouse gas emissions, market and employment development opportunities, and reduction of municipal wood residues at area landfills. Important issues that must be addressed to enable cofiring include wood chip uniformity and quality, fuel mixing procedures, transportation and wood chip processing costs, infrastructure requirements, and long-term biomass supply. Additional steps in implementing successful cofiring programs could include test burns, an assessment of area biomass supply and treatment needs, and a detailed economic and technical feasibility study. Although Fairbanks North Star Borough is well positioned to use biomass for cofiring at coal burning facilities, long-term cofiring operations would require expansion of biomass sources beyond defensible-space-related clearings alone. Long-term sources could potentially include a range of woody materials including forest harvesting residues, sawmill residues, and municipal wastes.

Officers found the body of a woman in her 40s on Friday morning

My Fuel Treatment Planner (MyFTP) is a tool for calculating and displaying the financial costs and potential revenues associated with forest fuel reduction treatments. It was designed for fuel treatment planners including those with little or no background in economics, forest management, or timber sales. This guide provides the information needed to acquire, load, and begin to use MyFTP.

The purpose of this note is to provide a starting point for discussion of fire hazard reduction treatments that meet the full range of management objectives, including budget priorities. Thoughtful design requires an understanding not only of the physical and biological outcomes, but also the costs and potential revenues of applying variations of fire hazard reduction treatments in a wide range of stand conditions. This analysis was done with My Fuel Treatment Planner software and provides estimates of cost and net revenue from fire hazard reduction treatments on 18 dry forest stands from 9 national forests in the Western United States. The data and software tools used in this analysis are all available, so these analyses can be easily modified to address a wider range of treatments and conditions.

The Landscape Treatment Designer (LTD) is a multicriteria spatial prioritization and optimization system to help design and explore landscape fuel treatment scenarios. The program fills a gap between fire model programs such as FlamMap, and planning systems such as ArcFuels, in the fuel treatment planning process. The LTD uses inputs on spatial treatment objectives, activity constraints, and treatment thresholds, and then identifies optimal fuel treatment locations with respect to the input parameters.

To increase timber production and manage other forest resource values, some land managers have undertaken logging debris and vegetation control treatments after forest harvest. We explored the roles of clearcutting on plant community composition and structure at three sites where logging debris was dispersed, piled, or removed and vegetation was annually treated or not treated with herbicides for 5 years. Without vegetation control, a competitive relation was identified between exotic and native ruderal (i.e., disturbance-associated) species. When exotic ruderal cover changed by 4 percent, native ruderal cover changed by 10 percent in the opposite direction. This relation was independent of site, but site was important in determining the overall dominance of ruderals. Five annual vegetation control treatments increased Douglas-fir (Pseudotsuga menziesii (Mirb.) Franco) growth, but decreased richness and cover of other species at the rate of one species per 10 percent reduction in cover. Debris treatment effects were small and found on only one site.

Kalydeco is the first medicine in Europe to treat the underlying cause of the disease

Statement Highlight: Resistant blood pressure affects 12 percent to 15 percent of people currently being treated for high blood pressure.

Statement Highlights: High cholesterol, at any age, can increase a person’s lifetime risk for heart disease and stroke. A healthy lifestyle is the first step in prevention and treatment to lower that risk. The 2018 guidelines recommend more detailed risk assessments to help health care providers better determine a person’s individualized risk and treatment options. In some cases, a coronary artery calcium score can help determine a person’s need for cholesterol-lowering treatment, if their risk status is uncertain or if the treatment decision isn't clear.

Focused Update Highlights: Newer anticoagulants, known as non-vitamin K oral anticoagulants (NOACs), are recommended over the traditional warfarin to prevent stroke in people with atrial fibrillation (AFib). Weight loss is recommended for overweight or obese people with AFib.

Statement Highlights: In a new scientific statement, the American Heart Association supports the creation of specialized multidisciplinary clinical programs that combine cardiovascular medicine and genetics expertise. These specialized programs would use genetic information to better treat patients with inherited heart conditions, as well as assess family members without current heart problems and take steps to reduce their risk.

People with type 2 diabetes are at an increased risk for heart failure and many people have both diseases, which requires careful medical management.

Statement Highlights: Geriatric conditions such as frailty, cognitive impairment, taking multiple medications and having multiple medical conditions complicate care for older people with acute cardiovascular diseases. Most research on how to treat...

Statement Highlights: Fulminant myocarditis develops quickly and can prove fatal without early recognition and advanced medical therapy. A new scientific statement from the American Heart Association details the resources needed to diagnose and treat...

Embargoed until 8 a.m. CT/9 a.m. ET, Tuesday, March 17, 2020   DALLAS, Tuesday, March 17, 2020 – As the global impact of COVID-19 rises, the scientific community continues to evaluate the clinical impact and health care needs of patients with...

AHA COVID-19 newsroom     DALLAS, May 4, 2020 — The American Heart Association, together with 14 cardiovascular societies in North America, today issued joint guidance, “Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic:...

Research Highlights: Mechanical clot removal alone may be as effective as combining it with intravenous (IV) clot-busting medications for stroke patients.    Mechanical clot removal alone reduced the risk of brain bleeding in this Japanese...

Research Highlights: A robot was used to treat brain aneurysms for the first time. The robotic system could eventually allow remote surgery, enabling surgeons to treat strokes from afar. Embargoed until 11:15 a.m. Pacific Time / 2:15 p.m. Eastern ...

A lot to look forward to in 2017. How did 2016 treat you: ???? or ????? (at San Francisco, California)

Suicide attempts common in post-concussion patients, says Dr. Charles Tator of the Canadian Concussion Centre

In the years since he had returned from Vietnam, Elmer “Snubby” Burket was a self-described workaholic, raising a son, keeping up his house and always taking jobs where he could be by himself as he tried to put the war behind him.

Q: I recently read that a combination of the drugs hydroxychloroquine and azithromycin might be effective against COVID-19. I have diabetes and I am at risk for this viral infection.…

The present invention relates to a process for preparing a compound of formula wherein: R2 is cycloalkyl or alkyl, each of which may be optionally substituted; Y is —CONR3R4, —CN or CO2R5; R3, R4 and R5 are each independently H or alkyl; n is 1 to 6; wherein said process comprising the steps of: (i) treating a compound of formula (IV), where R1 is alkyl, with a compound of formula (V) and forming a compound of formula (IIIb); (ii) treating said compound of formula (IIIb) with a compound of formula (I1) to form a compound of formula (I).

Provided are an anti-static and anti-microbial surface treatment agent including a quaternary ammonium salt compound as an active ingredient and a method of preventing a polymer fiber from developing static electricity by using the surface treatment agent. The quaternary ammonium salt compound has excellent anti-static and anti-microbial effects for the prevention or improvement of static electricity in a polymer fiber. Accordingly, the quaternary ammonium salt compound is suitable for use as a fabric softener, or an anti-static agent, and also, provides anti-microbial effects to a polymer fiber.

The present invention provides a use of a lipid composition for the preparation of a nutritional, pharmaceutical or nutraceutical composition or a functional food, for the prevention and treatment of gastrointestinal diseases and disorders, and for promoting intestinal development, maturation, adaptation and differentiation.

A glycerol derivative which is effective to reduce blood pressure and has the formula: ##STR1## wherein R1 is an alkyl group having 10-22 carbon atoms, R2 is a lower acyl group or benzoyl, each of R3 and R4 independently is hydrogen or a straight or branched chain alkyl group having 1-6 carbon atoms; each of R5, R6 and R7 independently is hydrogen, a straight or branched chain alkyl group having 1-6 carbon atoms, an aryl group or an aralkyl group; and each of m and n independently is 0 or a positive integer under the condition of m+n=2-8.

The present invention relates to novel heterocycle-substituted diphosphonic acids, and the pharmaceutically-acceptable salts and esters thereof, in which the diphosphonate-substituted carbon atom moiety is attached to a carbon atom in a nitrogen-containing six membered ring heterocycle, preferably a piperidine ring. The heterocycle-substituted diphosphonic acid compounds have the general structure: ##STR1## wherein Z is a nitrogen-containing six membered ring heterocycle moiety selected from piperidinyl, diazinyl and triazinyl; m, n and m+n are from 0 to 10; Q is a covalent bond or a moiety selected from oxygen, sulfur or nitrogen; and R1, R2, R3 and R4 are substituent groups.The present invention further relates to pharmaceutical compositions containing these novel compounds. Finally this invention relates to methods for treating or preventing diseases characterized by abnormal calcium and phosphate metabolism by utilizing a compound or pharmaceutical composition of the present invention.

A method of treating hepatitis virus infection is disclosed. The method comprising administering to a human subject in need of such treatment an effective hepatitis virus-combatting amount of an alkyl lipid or alkyl lipid derivative.

A method of treating hepatitis virus infection is disclosed. The method comprising administering to a human subject in need of such treatment an effective hepatitis virus-combatting amount of an alkyl lipid or alkyl lipid derivative.

An alumino-borosilicate glass for the confinement, isolation of a radioactive liquid effluent of medium activity, and a method for treating a radioactive liquid effluent of medium activity, wherein calcination of said effluent is carried out in order to obtain a calcinate, and a vitrification adjuvant is added to said calcinate.

A process for the production of aromatics through the reforming of a hydrocarbon stream is presented. The process utilizes the differences in properties of components within the hydrocarbon stream to increase the energy efficiency. The differences in the reactions of different hydrocarbon components in the conversion to aromatics allows for different treatments of the different components to reduce the energy used in reforming process.

Provided is a surface treated calcium carbonate filler for resins, which comprises calcium carbonate particles, the surface of which has been treated with at least one surface active agent (A) selected from the group consisting of saturated fatty acids, unsaturated fatty acids, alicyclic carboxylic acids, resin acids, and salts thereof and with at least one compound (B) having the ability to chelate alkaline earth metals, the compound (B) being selected from the group consisting of phosphonic acids, polycarboxylic acids, and salts thereof. The surface treated calcium carbonate filler for resins of the present invention deteriorates little with time, has satisfactory dispersibility in resins, and can give a sheet or film which has a satisfactory balance among durability, weatherability, strength, and thermal stability, and is useful as a battery separator or a light reflector.

Disclosed herein are surface treatments for soft silicone gel materials such as silicone intraocular lenses.

The invention relates to the treatment of carbonaceous radioactive waste, comprising the delivery of waste to one or more radioactive isotope separation stations isotopes, said isotopes being among at least carbon 14, chlorine 36, and tritium. Advantageously, the delivery to each of the stations occurs in wet form, with water being a common medium for conveying the waste to each of the separation stations.

A method is provided for the decontamination of radioactive carbonaceous material, such as graphite, in which an injection of steam is planned into the material, concurrent with a first roasting thermal treatment of the material at a temperature between 1200° C. and 1500° C. Advantageously, the first treatment may be followed by a second treatment at a lower temperature with an injection of carbon oxide for oxidation according to the Boudouard reaction.

The present invention relates to a process for the treatment of hazardous waste, the process comprising: (i) providing a hazardous waste; (ii) providing a further waste; (iii) plasma treating the hazardous waste in a first plasma treatment unit, (iv) gasifying the further waste in a gasification unit to produce an offgas and a char material; and (v) plasma treating the offgas, and optionally the char material, in a second plasma treatment unit to produce a syngas, (vi) optionally treating the syngas in a gas cleaning plant, wherein the first plasma treatment unit is arranged to plasma treat at least some of the solid by-products from the gasification unit and/or the second plasma treatment unit and/or the gas cleaning plant.

A continuous process for the thermal treatment of a refinery sludge, comprising the following operations: a. drying of the refinery sludge, possibly mixed with pet-coke, at a temperature ranging from 110 to 120° C.; b. gasification of the dried sludge, at a temperature ranging from 750 to 950° C., for a time of 30 to 60 minutes, in the presence of a gas containing oxygen and water vapour, with the associated production of synthesis gas (CO+H2) and a solid residue; c. combustion of the synthesis gas at a temperature ranging from 850 to 1,200° C. and recycling of the combustion products for the drying and gasification phases; and d. inertization of the solid residue, at a temperature ranging from 1,300 to 1,500° C., by vitrification with plasma torches.